Feature | December 23, 2013

WHO Study: Atrial Fibrillation is a Growing Global Health Concern

December 23, 2013 — Atrial fibrillation (AF), long considered the most common condition leading to an irregular heartbeat, is a growing and serious global health problem, according to the first study ever to estimate the condition’s worldwide prevalence, death rates and societal costs.
 
The World Health Organization (WHO) data analysis, led by Sumeet Chugh, M.D., associate director, Cedars-Sinai Heart Institute, shows 33.5 million people worldwide — or 0.5 percent of the world’s population — have the condition. Funded partly by the Bill & Melinda Gates Foundation and the Cedars-Sinai Heart Institute, the analysis was conducted with the assistance of the University of Washington University’s Institute for Health Metrics and Evaluation.
 
The study, believed to be the first to determine the number of people globally with AF, is published online in the peer reviewed medical journal Circulation and is scheduled to be published in the Feb. 25 print edition of the journal.
 
“Atrial fibrillation has a huge cost in every sense of the word,” said Chugh. “It can lead to stroke, hospitalization, as well as lost productivity. Our findings indicate that atrial fibrillation is on the rise around the world and it’s a huge public health burden.”
 
During the analysis, Chugh and a team of researchers systematically analyzed data from selected population-based research studies — from among 1,784 published medical research studies on AF — to estimate global and regional prevalence, incidence and mortality related to this condition.
 
“Finding out the scope of the problem is step No. 1,” said Chugh. “Our hope is that we can develop a sustainable global plan to manage atrial fibrillation and find new and effective ways of preventing this condition.”
 
Among the study’s findings:
  • In 1990, an estimated 570 of 100,000 men had AF. In 2010, the prevalence rate for men was 596 of 100,000.
  • For females, an estimated 360 of 100,000 women had AF in 1990. In 2010, that rose to 373 of 100,000.
  • In 1990, the number of new cases of AF in men was estimated at 61 per 100,000. In 2010, the number of men with new cases of AF rose to 78 per 100,000.
  • The number of new cases of AF in women was 43 per 100,000 in 1990. In 2010, the number of new cases in women was 60 per 100,000.
  • Although deaths linked to AF are rising around the world, more women with AF are dying in developing countries. In the United States, deaths linked to AF now are comparable between the sexes.
 
“A lot more research is needed to fully understand this continuing worldwide increase,” said Chugh. “Although the chance of developing atrial fibrillation does increase with age, these findings are not entirely explained by the aging world population. Several other factors have been suggested and need to be better evaluated, from obesity and hypertension to air pollution.”
 
For more information: cedars-sinai.edu, circ.ahajournals.org

Related Content

ACC.17 late breaking trial presentations, ACC late-breakers,  American College of Cardiology late breaking studies
Feature | ACC| February 28, 2017
The American College of Cardiology (ACC) has announced the late-breaking clinical trails that will be presented at it
common adult CT examinations, computed tomography, diagnostic reference levels, DRLs, radiation dose, achievable dose, AD
News | Radiation Dose Management| February 23, 2017
Using data from the world’s largest computed tomography (CT) dose index registry, researchers have established national...
News | Cardiac Diagnostics| February 17, 2017
Levels of a protein in the blood associated with heart disease are also linked to early-stage brain damage, according...
Medtronic, expanded indication, Freezor Xtra Cryoablation Catheter, AVNRT, atrioventricular nodal re-entrant tachycardia
Technology | Ablation Systems| February 16, 2017
Medtronic plc announced the U.S. Food and Drug Administration (FDA) has approved its Freezor Xtra Cryoablation Catheter...
Mercator MedSystems, DANCE trial data, ISET, LINC, Bullfrog Micro-Infusion Device
News | Peripheral Arterial Disease (PAD)| February 15, 2017
Mercator MedSystems announced that the national co-principal investigators of the company’s DANCE trial each presented...
Biotronik, ProMRI Configurator tool, MR-conditional cardiac devices, ProMRI SystemCheck
Technology | Implantable Cardiac Monitor (ICM)| February 14, 2017
Biotronik has developed an online tool that streamlines the workflow for physicians selecting the right magnetic...
News | Hypertension| February 13, 2017
Vascular Dynamics Inc. (VDI) announced that the U.S. Food and Drug Administration (FDA) has approved the company’s...
Xarelto, rivaroxaban, COMPASS study, ends early,
News | Antiplatelet and Anticoagulation Therapies| February 09, 2017
February 9, 2017 — Janssen Research & Development LLC (Janssen) announced that the Phase 3 COMPASS trial is stopp
Medtronic, IDE approval, IN.PACT Admiral drug-coated balloon, DCB, end-stage renal disease
News | Drug-Eluting Balloons| February 08, 2017
Medtronic plc announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug Administration...
CSI, LIBERTY 360 Study, ISET 2017, six-month data, lower extremity PAD
News | Atherectomy Devices| February 08, 2017
February 8, 2017 — Cardiovascular Systems (CSI) presented six-month data from its LIBERTY 360° post-market study in a
Overlay Init